Inventiva (IVEVF) Other Accumulated Expenses (2018 - 2025)
Inventiva (IVEVF) posted Other Accumulated Expenses of $20.9 million for Q4 2025, up 21.89% on a QoQ basis from $17.2 million in Q2 2025, and up 127.76% year-over-year from $9.2 million in Q4 2024.
Analysis
Inventiva (IVEVF) Other Accumulated Expenses (2018 - 2025) Analysis & Trends
Inventiva has reported Other Accumulated Expenses for 8 years, with the latest figure at $20.9 million in Q4 2025.
- On a quarterly basis, Other Accumulated Expenses rose 127.76% year-over-year to $20.9 million in Q4 2025; TTM through Dec 2025 was $20.9 million, a 127.76% increase from a year earlier, with the FY2025 full-year figure at $20.9 million, up 127.76% from the prior year.
- Other Accumulated Expenses was $20.9 million for Q4 2025 at Inventiva, up from $17.2 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $20.9 million in Q4 2025, with the low at $5.0 million in Q2 2022.
- Average Other Accumulated Expenses over 5 years is $9.0 million, with a median of $7.7 million recorded in 2023.
- The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses soared 131365.87% in 2021, then decreased 27.95% in 2022.
- Over 5 years, Other Accumulated Expenses stood at $7.8 million in 2021, then fell by 27.95% to $5.6 million in 2022, then surged by 37.76% to $7.7 million in 2023, then rose by 19.21% to $9.2 million in 2024, then jumped by 127.76% to $20.9 million in 2025.
- The last three Other Accumulated Expenses figures came in at $20.9 million (Q4 2025), $17.2 million (Q2 2025), and $9.2 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.95 Bn | 625.20 Bn | 17.26 Bn |
| 2 | AbbVie | 441.39 Bn | 434.82 Bn | 12.70 Bn |
| 3 | Merck | 366.72 Bn | 359.58 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.68 Bn | 258.99 Bn | 11.24 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.50 Bn | 20.96 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 20.93 Mn |
| Jun 30, 2025 | 17.17 Mn |
| Dec 31, 2024 | 9.19 Mn |
| Jun 30, 2024 | 6.25 Mn |
| Dec 31, 2023 | 7.71 Mn |
| Jun 30, 2023 | 5.42 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Jun 30, 2022 | 5.01 Mn |
| Dec 31, 2021 | 7.77 Mn |
| Jun 30, 2021 | 5.43 Mn |
| Mar 31, 2021 | 8.71 Mn |
| Dec 31, 2020 | 8.15 Mn |
| Jun 30, 2020 | 5.88 Mn |
| Mar 31, 2020 | 6,623.63 |
| Dec 31, 2019 | 5.53 Mn |
| Dec 31, 2018 | 5.56 Mn |